Crossmark

Palivizumab Exposure and the Risk of Atopic Dermatitis, Asthma and Allergic Rhinoconjunctivitis: A Cross-National, Population-Based Cohort Study

Crossref DOI link: https://doi.org/10.1007/s40272-017-0215-7

Published Online: 2017-02-10

Published Print: 2017-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Haerskjold, Ann

Stokholm, Lonny

Linder, Marie

Thomsen, Simon Francis

Bergman, Gunnar

Berglind, Ingegärd Anveden

Kieler, Helle

Ravn, Henrik

Stensballe, Lone Graff
Funding

Funding for this research was provided by:

AbbVie
License Information

License valid from 2017-02-10